An active substance in the spice oregano may display potential as a treatment for inflammatory disorders such as osteoporosis and arteriosclerosis, according to a study published in the Proceedings of the National Academy of Sciences.
Beta-caryophyllin (E-BCP), also found in basil, rosemary, cinnamon and black pepper, docks with cannabinoid-CB2 receptors and inhibits the cell's production of phlogogenic signal substances. Researchers at Bonn University in Germany fed the substance to mice with inflamed paws. Seven out of 10 of the animals later showed improvement of symptoms.
Many natural substances that affect the CB2 receptor, cannabis, for example, also affect CB1, which can produce intoxication. E-BCP is the first natural agent that only targets CB2, and has no such effect.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze